Parathyroid hormone enhances osteoblast differentiation from human skin derived precursor cells in vitro

Journal of the Medical Association of Thailand

Volumn 94, Issue 10 SUPPL., 2011, Pages

  Suriyachand, Katesaree ^a,b   Bunyaratvej, Ahnond ^b,d   Bunyaratavej, Narong ^c   Sila Asna, Monnipha ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d PYY FOUNDATION (Foundation for Sustainable Development) Samutsakron   (Thailand)

Author keywords

Osteoblast; Osteoblast differentiation; Parathyroid hormone (PTH); Skin derived precursors cell (SKPs); Stem cell

Indexed keywords

ALKALINE PHOSPHATASE; BONE SIALOPROTEIN; OSTEOCALCIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BIOSYNTHESIS; BONE DEVELOPMENT; BONE MATRIX; CBFA1 GENE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME ASSAY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN SKIN DERIVED PRECURSOR CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; OSTEOBLAST; OSTEOCLAST; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEM CELL; CYTOLOGY; METABOLISM; OSTEOPOROSIS; PHYSIOLOGY; SKIN;

BONE MATRIX; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION; HUMANS; MALE; OSTEOBLASTS; OSTEOPOROSIS; PARATHYROID HORMONE; SKIN;

EID: 84858050415     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Buranasinsup S, Sila-Asna M, Bunyaratvej N, Bunyaratvej A. In vitro osteogenesis from human skin-derived precursor cells. Dev Growth Differ 2006; 48: 263-9.
2. Sila-Asna M, Bunyaratvej A, Maeda S, Kitaguchi H, Bunyaratavej N. Osteoblast differentiation and bone formation gene expression in strontium-inducing bone marrow mesenchymal stem cell. Kobe J Med Sci 2007; 53: 25-35.
3. Girotra M, Rubin MR, Bilezikian JP. Anabolic skeletal therapy for osteoporosis. Arq Bras Endocrinol Metabol 2006; 50: 745-54.
4. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344: 1434-41.
5. Potts JT. Parathyroid hormone: past and present. J Endocrinol 2005; 187: 311-25.
6. Swarthout JT, D'Alonzo RC, Selvamurugan N, Partridge NC. Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 2002; 282: 1-17.
7. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-54.
8. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89: 755-64.
9. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997; 89: 765-71.
10. Ducy P. Cbfa1: a molecular switch in osteoblast biology. Dev Dyn 2000; 219: 461-71.
11. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 1999; 13: 1025-36.
12. Xiao G, Jiang D, Ge C, Zhao Z, Lai Y, Boules H, et al. Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast- specific osteocalcin gene expression. J Biol Chem 2005; 280: 30689-96.
13. Perinpanayagam H, Martin T, Mithal V, Dahman M, Marzec N, Lampasso J, et al. Alveolar bone osteoblast differentiation and Runx2/Cbfa1 expression. Arch Oral Biol 2006; 51: 406-15.
14. Lian JB, Stein GS. Runx2/Cbfa1: a multifunctional regulator of bone formation. Curr Pharm Des 2003; 9: 2677-85.
15. Stein GS, Lian JB. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 1993; 14: 424-42.
16. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000; 21: 115-37.
17. Hadjidakis DJ, Androulakis II. Bone remodeling. Ann N Y Acad Sci 2006; 1092: 385-96.